What This Therapeutics Insider Signals Revenue Momentum
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
We compare index funds and target date funds for retirement to help you decide based on time horizon, risk tolerance, costs, and tax considerations.
26,044 articlesA high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
tech stocks led a broad rally as Nvidia fueled AI optimism. This look at the stock market today, feb., explains what...
The White House announced the creation of a tech policy advisory council, naming Mark Zuckerberg, Jensen Huang, and L...
Local towns are pushing back on megascale data centers even as tech giants accelerate capex toward a multi-trillion-d...
A Brookings study released this spring estimates ICE enforcement costs the economy about 668,000 jobs, unraveling the...
A New York man was sentenced to 15 months in federal prison for running a Telegram-based crypto fraud that netted abo...
Trust in the FDA is faltering as political pressures collide with science. This piece explains why transparency matte...
A late 2025 study finds workers would sacrifice up to a quarter of compensation to keep remote work options. The resu...
Iran publicly spurns ceasefire talks amid renewed attacks, while the White House insists talks continue. The flare-up...
Lawmakers unveil a plan centered on a common-sense approach housing affordability to address supply and cost hurdles....
A sharp intraday slide in D-Wave Quantum shares has many investors rattled. This guide breaks down what caused the mo...
As markets adjust to higher-for-longer rates, three Dividend Kings stand out as defensive anchors for a $1.5 million ...